Hudson Valley Investment Advisors Inc. ADV cut its position in shares of Cigna Corp (NYSE:CI) by 18.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,654 shares of the health services provider’s stock after selling 594 shares during the period. Hudson Valley Investment Advisors Inc. ADV’s holdings in Cigna were worth $418,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in CI. Cornerstone Advisors Inc. increased its position in Cigna by 32.7% in the 2nd quarter. Cornerstone Advisors Inc. now owns 1,254 shares of the health services provider’s stock valued at $198,000 after acquiring an additional 309 shares during the period. Factory Mutual Insurance Co. acquired a new stake in shares of Cigna during the second quarter worth $15,440,000. Thoroughbred Financial Services LLC increased its position in shares of Cigna by 15,133.6% during the second quarter. Thoroughbred Financial Services LLC now owns 276,185 shares of the health services provider’s stock worth $27,618,000 after buying an additional 274,372 shares during the period. IFM Investors Pty Ltd increased its position in shares of Cigna by 7.0% during the second quarter. IFM Investors Pty Ltd now owns 26,846 shares of the health services provider’s stock worth $4,230,000 after buying an additional 1,747 shares during the period. Finally, OLD National Bancorp IN increased its position in shares of Cigna by 7.1% during the second quarter. OLD National Bancorp IN now owns 8,992 shares of the health services provider’s stock worth $1,417,000 after buying an additional 599 shares during the period. Institutional investors own 87.92% of the company’s stock.
Several equities research analysts have recently weighed in on CI shares. Goldman Sachs Group cut shares of Cigna from a “conviction-buy” rating to a “buy” rating in a research report on Friday, May 3rd. Sanford C. Bernstein raised shares of Cigna from a “market perform” rating to an “outperform” rating and set a $205.00 price objective on the stock in a research note on Tuesday, August 6th. Raymond James raised their price objective on shares of Cigna from $185.00 to $190.00 and gave the company an “outperform” rating in a research note on Friday, August 2nd. Morgan Stanley dropped their price objective on shares of Cigna from $241.00 to $207.00 and set an “overweight” rating on the stock in a research note on Friday, July 12th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $245.00 price objective on shares of Cigna in a research note on Sunday, April 21st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $214.55.
Cigna (NYSE:CI) last issued its quarterly earnings data on Thursday, August 1st. The health services provider reported $4.30 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.74 by $0.56. The business had revenue of $34.38 billion for the quarter, compared to the consensus estimate of $33.27 billion. Cigna had a net margin of 3.60% and a return on equity of 13.24%. The company’s quarterly revenue was up 198.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.89 EPS. Equities research analysts anticipate that Cigna Corp will post 16.59 earnings per share for the current year.
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Featured Article: Trade War
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.